Displaying drugs 10326 - 10350 of 10872 in total
Depreotide
Depreotide is an ingredient in the EMA-withdrawn product NeoSpect.
Withdrawn
Matched Description: … Depreotide is an ingredient in the EMA-withdrawn product NeoSpect. …
Flubendazole
Flubendazole is an anthelmintic that is used to treat worm infection in humans. It is available OTC in Europe.
Experimental
Withdrawn
Matched Description: … It is available OTC in Europe. ... Flubendazole is an anthelmintic that is used to treat worm infection in humans. …
Glucoraphanin
Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]).
Investigational
Matched Description: … in Advanced Pancreatic Cancer [POUDER Trial]). ... Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts …
MOL-4239
MOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis).
Investigational
Matched Description: … Study to Evaluate MOL4239 in Psoriasis). ... MOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, …
BTRX-335140
BTRX-335140 is under investigation in clinical trial NCT04221230 (Study in Major Depressive Disorder With BTRX-335140 vs Placebo).
Investigational
Matched Description: … BTRX-335140 is under investigation in clinical trial NCT04221230 (Study in Major Depressive Disorder …
Pecavaptan
Pecavaptan is under investigation in clinical trial NCT03901729 (A Trial to Study BAY1753011 in Patients With Congestive Heart Failure).
Investigational
Matched Description: … Pecavaptan is under investigation in clinical trial NCT03901729 (A Trial to Study BAY1753011 in Patients …
Gatipotuzumab
Gatipotuzumab is under investigation in clinical trial NCT01899599 (Pankomab-gex™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer).
Investigational
Matched Description: … Therapy in Advanced Ovarian Cancer). ... Gatipotuzumab is under investigation in clinical trial NCT01899599 (Pankomab-gex™ Versus Placebo as Maintenance …
Vamikibart
Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema).
Investigational
Matched Description: … Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in …
Narlumosbart
Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease).
Investigational
Matched Description: … in Patients With Multiple Myeloma Bone Disease). ... Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab …
Utidelone
Utidelone (UTD1), a novel microtubule stabilizing agent, is an epothilone B analogue produced by genetic engineering.[A257544,A257549] It is under investigation in clinical trials for various cancers.
Investigational
Matched Description: … [A257544,A257549] It is under investigation in clinical trials for various cancers. …
4-Methyl-2,5-dimethoxyamphetamine
A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD.
Experimental
Illicit
Matched Description: … action may be similar to those of LSD. ... psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of …
Endostar
Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.
Investigational
Matched Description: … Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. ... Endostar has been investigated for the treatment of Non-small Cell Lung Cancer. …
Zeranol
Zeranol is a non-steroidal estrogen agonist. It is a mycotoxin, derived from fungi in the Fusarium family, and may be found as a contaminant in fungus-infected crops. It is 3-4x more potent as an estrogen agonist than the related compound zearalenone.
Experimental
Vet approved
Matched Description: … It is a mycotoxin, derived from fungi in the Fusarium family, and may be found as a contaminant in fungus-infected …
JPC-3210
JPC-3210 is a potent antimalarial agent. It is an erythrocytic schizonticide with potent in vitro antimalarial activity against multidrug-resistant Plasmodium falciparum lines, low cytotoxicity, potent in vivo efficacy against murine malaria, and favourable preclinical pharmacokinetics including a lengthy plasma elimination half-life.
Experimental
Matched Description: … _Plasmodium falciparum_ lines, low cytotoxicity, potent in vivo efficacy against murine malaria, and ... It is an erythrocytic schizonticide with potent in vitro antimalarial activity against multidrug-resistant …
Uridine-5'-Diphosphate
A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [PubChem]
Experimental
Matched Description: … A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [PubChem] …
Moxaverine
Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.
Investigational
Matched Description: … Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow …
Matched Salts cas: … 1163-37-7 …
Matched Salts cas: … 1163-37-7 …
Pimonidazole
Pimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer.
Investigational
Matched Description: … Pimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer. …
Glucagon-like peptide II
Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.
Investigational
Matched Description: … Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome. …
Actinium
Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.
Investigational
Matched Description: … Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive …
FLX475
FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.
Investigational
Matched Description: … FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875] …
NXC680
NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).
Investigational
Matched Description: … NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF …
Anecortave
Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension).
Investigational
Matched Description: … Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients …
Tramazoline
Tramazoline is under investigation in clinical trial NCT01601509 (Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and).
Investigational
Matched Description: … in Obstructive Sleep Apnea (OSA) Patients Tramazoline and). ... Tramazoline is under investigation in clinical trial NCT01601509 (Nasal Tramazoline and Dexamethazone …
Vorolanib
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Investigational
Matched Description: … Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced …
Acalisib
Acalisib is under investigation in clinical trial NCT01705847 (A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies).
Investigational
Matched Description: … Acalisib is under investigation in clinical trial NCT01705847 (A Phase 1b Study Evaluating GS-9820 in …
Displaying drugs 10326 - 10350 of 10872 in total